|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okines A, Verheij M, Allum W, Cunningham D
and Cervantes A; ESMO Guidelines Working Group, : Gastric cancer:
ESMO clinical practice guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 21 (Suppl 5):v50–v54. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wei J, Liu CJ and Li Z: ADAMTS-18: A
metalloproteinase with multiple functions. Front Biosci (Landmark
Ed). 19:1456–1467. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ataca D, Caikovski M, Piersigilli A,
Moulin A, Benarafa C, Earp SE, Guri Y, Kostic C, Arsenijevic Y,
Soininen R, et al: Adamts18 deletion results in distinct
developmental defects and provides a model for congenital disorders
of lens, lung, and female reproductive tract development. Biol
Open. 5:1585–1594. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kelwick R, Desanlis I, Wheeler GN and
Edwards DR: The ADAMTS (A Disintegrin and Metalloproteinase with
Thrombospondin motifs) family. Genome Biol. 16:1132015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu H, Xiao Q, Fan Y, Xiang T, Li C, Li C,
Li S, Hui T, Zhang L, Li H, et al: Epigenetic silencing of ADAMTS18
promotes cell migration and invasion of breast cancer through AKT
and NF-κB signaling. Cancer Med. 6:1399–1408. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang L, Liu Y and Zheng P: Downregulation
of ADAMTS18 May serve as a poor prognostic biomarker for cervical
cancer patients. Appl Immunohistochem Mol Morphol. 26:670–675.
2018.PubMed/NCBI
|
|
9
|
Jin H, Wang X, Ying J, Wong AH, Li H, Lee
KY, Srivastava G, Chan AT, Yeo W, Ma BB, et al: Epigenetic
identification of ADAMTS18 as a novel 16q23.1 tumor suppressor
frequently silenced in esophageal, nasopharyngeal and multiple
other carcinomas. Oncogene. 26:7490–7498. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
|
|
11
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM Classification of Malignant Tumours. 8th. John
Wiley & Sons; Hoboken, NJ, USA: 2017
|
|
13
|
Batey L, Moon JE, Yu Y, Wu B, Hirschhorn
JN, Shen Y and Dauber A: A novel deletion of IGF1 in a patient with
idiopathic short stature provides insight Into IGF1
haploinsufficiency. J Clin Endocrinol Metab. 99:E153–E159. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47(D1): D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
López-Otín C and Matrisian LM: Emerging
roles of proteases in tumour suppression. Nat Rev Cancer.
7:800–808. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumar S, Rao N and Ge R: Emerging roles of
ADAMTSs in angiogenesis and cancer. Cancers (Basel). 4:1252–1299.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wagstaff L, Kelwick R, Decock J and
Edwards DR: The roles of ADAMTS metalloproteinases in tumorigenesis
and metastasis. Front Biosci (Landmark Ed). 16:1861–1872. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zeng W, Corcoran C, Collins-Racie LA,
Lavallie ER, Morris EA and Flannery CR: Glycosaminoglycan-binding
properties and aggrecanase activities of truncated ADAMTSs:
Comparative analyses with ADAMTS-5, −9, −16 and −18. Biochim
Biophys Acta. 1760:517–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Nardi MA, Li YS, Zhang W, Pan R,
Dang S, Yee H, Quartermain D, Jonas S and Karpatkin S: C-terminal
ADAMTS-18 fragment induces oxidative platelet fragmentation,
dissolves platelet aggregates, and protects against carotid artery
occlusion and cerebral stroke. Blood. 113:6051–6060. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Z, Zhang W, Shao Y, Zhang C, Wu Q, Yang
H, Wan X, Zhang J, Guan M, Wan J and Yu B: High-resolution melting
analysis of ADAMTS18 methylation levels in gastric, colorectal and
pancreatic cancers. Med Oncol. 27:998–1004. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei X, Prickett TD, Viloria CG, Molinolo
A, Lin JC, Cardenas-Navia I, Cruz P; NISC Comparative Sequencing
Program, ; Rosenberg SA, Davies MA, et al: Mutational and
functional analysis reveals ADAMTS18 metalloproteinase as a novel
driver in melanoma. Mol Cancer Res. 8:1513–1525. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Malik R, Lelkes PI and Cukierman E:
Biomechanical and biochemical remodeling of stromal extracellular
matrix in cancer. Trends Biotechnol. 33:230–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun Y, Huang J and Yang Z: The roles of
ADAMTS in angiogenesis and cancer. Tumour Biol. 36:4039–4051. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martino-Echarri E, Fernández-Rodríguez R,
Rodríguez-Baena FJ, Barrientos-Durán A, Torres-Collado AX,
Plaza-Calonge Mdel C, Amador-Cubero S, Cortés J, Reynolds LE,
Hodivala-Dilke KM, et al: Contribution of ADAMTS1 as a tumor
suppressor gene in human breast carcinoma. Linking its tumor
inhibitory properties to its proteolytic activity on nidogen-1 and
nidogen-2. Int J Cancer. 133:2315–2324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ocak Z, Acar M, Gunduz E, Gunduz M,
Demircan K, Uyeturk U and Ozlü T: Effect of hypericin on the
ADAMTS-9 and ADAMTS-8 gene expression in MCF7 breast cancer cells.
Eur Rev Med Pharmacol Sci. 17:1185–1190. 2013.PubMed/NCBI
|
|
29
|
Fontanil T, Rúa S, Llamazares M,
Moncada-Pazos A, Quirós PM, García-Suárez O, Vega JA, Sasaki T,
Mohamedi Y, Esteban MM, et al: Interaction between the ADAMTS-12
metalloprotease and fibulin-2 induces tumor-suppressive effects in
breast cancer cells. Oncotarget. 5:1253–1264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo X, Li J, Zhang H, Liu H, Liu Z and Wei
X: Relationship between ADAMTS8, ADAMTS18, and ADAMTS20 (A
Disintegrin and Metalloproteinase with Thrombospondin Motifs)
expressions and tumor molecular classification, clinical
pathological parameters, and prognosis in breast invasive ductal
carcinoma. Med Sci Monit. 24:3726–3735. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Held-Feindt J, Paredes EB, Blömer U,
Seidenbecher C, Stark AM, Mehdorn HM and Mentlein R:
Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and
metalloproteinases with thrombospondin motifs 4 and 5) are
expressed in human glioblastomas. Int J Cancer. 118:55–61. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ishikawa N, Daigo Y, Yasui W, Inai K,
Nishimura H, Tsuchiya E, Kohno N and Nakamura Y: ADAM8 as a novel
serological and histochemical marker for lung cancer. Clin Cancer
Res. 10:8363–8370. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ko SY, Lin SC, Wong YK, Liu CJ, Chang KW
and Liu TY: Increase of disintergin metalloprotease 10 (ADAM10)
expression in oral squamous cell carcinoma. Cancer Lett. 245:33–43.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lendeckel U, Kohl J, Arndt M, Carl-McGrath
S, Donat H and Röcken C: Increased expression of ADAM family
members in human breast cancer and breast cancer cell lines. J
Cancer Res Clin Oncol. 131:41–48. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kilic MO, Aynekin B, Kara A, Icen D and
Demircan K: Differentially regulated ADAMTS1, 8, and 18 in gastric
adenocarcinoma. Bratisl Lek Listy. 118:71–76. 2017.PubMed/NCBI
|
